150 related articles for article (PubMed ID: 21609665)
1. [Thalassemia: therapeutic hopes carried by hepcidin].
Vaulont S; Labie D
Med Sci (Paris); 2011 May; 27(5):473-5. PubMed ID: 21609665
[No Abstract] [Full Text] [Related]
2. Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia.
Breda L; Gardenghi S; Guy E; Rachmilewitz EA; Weizer-Stern O; Adamsky K; Amariglio N; Rechavi G; Giardina PJ; Grady RW; Rivella S
Ann N Y Acad Sci; 2005; 1054():417-22. PubMed ID: 16339690
[TBL] [Abstract][Full Text] [Related]
3. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
4. Exogenous iron increases hemoglobin in beta-thalassemic mice.
Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
[TBL] [Abstract][Full Text] [Related]
5. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.
Gardenghi S; Ramos P; Marongiu MF; Melchiori L; Breda L; Guy E; Muirhead K; Rao N; Roy CN; Andrews NC; Nemeth E; Follenzi A; An X; Mohandas N; Ginzburg Y; Rachmilewitz EA; Giardina PJ; Grady RW; Rivella S
J Clin Invest; 2010 Dec; 120(12):4466-77. PubMed ID: 21099112
[TBL] [Abstract][Full Text] [Related]
6. A tincture of hepcidin cures all: the potential for hepcidin therapeutics.
Bartnikas TB; Fleming MD
J Clin Invest; 2010 Dec; 120(12):4187-90. PubMed ID: 21099105
[TBL] [Abstract][Full Text] [Related]
7. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
[TBL] [Abstract][Full Text] [Related]
8. Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?
Rachmilewitz EA; Weizer-Stern O; Adamsky K; Amariglio N; Rechavi G; Breda L; Rivella S; Cabantchik ZI
Ann N Y Acad Sci; 2005; 1054():118-23. PubMed ID: 16339657
[TBL] [Abstract][Full Text] [Related]
9. Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression.
Frazer DM; Wilkins SJ; Darshan D; Badrick AC; McLaren GD; Anderson GJ
Br J Haematol; 2012 Jun; 157(5):615-26. PubMed ID: 22449175
[TBL] [Abstract][Full Text] [Related]
10. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major.
Kattamis A; Papassotiriou I; Palaiologou D; Apostolakou F; Galani A; Ladis V; Sakellaropoulos N; Papanikolaou G
Haematologica; 2006 Jun; 91(6):809-12. PubMed ID: 16769583
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
Porter JB
Hemoglobin; 2009; 33 Suppl 1():S37-45. PubMed ID: 20001631
[TBL] [Abstract][Full Text] [Related]
12. Iron imports. I. Intestinal iron absorption and its regulation.
Frazer DM; Anderson GJ
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G631-5. PubMed ID: 16160078
[TBL] [Abstract][Full Text] [Related]
13. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
Pasricha SR; Frazer DM; Bowden DK; Anderson GJ
Blood; 2013 Jul; 122(1):124-33. PubMed ID: 23656728
[TBL] [Abstract][Full Text] [Related]
14. [Hepcidin--the discovery of a small protein with a pivotal role in iron homeostasis].
Sela BA
Harefuah; 2008 Mar; 147(3):261-6, 276. PubMed ID: 18488871
[TBL] [Abstract][Full Text] [Related]
15. [Hepcidin: the Grail of iron metabolism].
Loréal O; Brissot P
Gastroenterol Clin Biol; 2002; 26(8-9):805-7. PubMed ID: 12434091
[No Abstract] [Full Text] [Related]
16. SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.
Vadolas J; Ng GZ; Kysenius K; Crouch PJ; Dames S; Eisermann M; Nualkaew T; Vilcassim S; Schaeper U; Grigoriadis G
Br J Haematol; 2021 Jul; 194(1):200-210. PubMed ID: 33942901
[TBL] [Abstract][Full Text] [Related]
17. A compartmental model of iron regulation in the mouse.
Lao BJ; Kamei DT
J Theor Biol; 2006 Dec; 243(4):542-54. PubMed ID: 16935308
[TBL] [Abstract][Full Text] [Related]
18. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia.
De Franceschi L; Daraio F; Filippini A; Carturan S; Muchitsch EM; Roetto A; Camaschella C
Haematologica; 2006 Oct; 91(10):1336-42. PubMed ID: 17018382
[TBL] [Abstract][Full Text] [Related]
19. GDF15 expression and iron overload in ineffective erythropoiesis.
Tanno T; Miller JL
Rinsho Ketsueki; 2011 Jun; 52(6):387-98. PubMed ID: 21737991
[No Abstract] [Full Text] [Related]
20. Iron absorption and metabolism.
Anderson GJ; Frazer DM; McLaren GD
Curr Opin Gastroenterol; 2009 Mar; 25(2):129-35. PubMed ID: 19528880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
